Form 4: Bio-Key International Executive Acquires Shares Under Employee Stock Purchase Plan

Mira LaCous, Chief Technology Officer of Bio-Key International, acquired 139 shares of common stock under the company's Employee Stock Purchase Plan.

Summary

• On June 28, 2024, Mira LaCous, the Chief Technology Officer of Bio-Key International, Inc., acquired 139 shares of common stock.
• The shares were purchased at a price of $1.394 per share under the company's 2021 Employee Stock Purchase Plan.
• Following the transaction, LaCous directly owns 1,480 shares of Bio-Key International, Inc.
• All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.
• Holdings do not include options to purchase 174 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction, and while insider buying can be seen as a positive signal, it's a small amount of shares purchased under a standard employee program.

Positives

• The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common among publicly traded companies. It provides transparency into the actions of company executives and their investment decisions regarding the company's stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The Employee Stock Purchase Plan is a common benefit offered by many companies, including competitors of Bio-Key International, to incentivize employee ownership.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency to shareholders regarding insider trading activity.

Key Dates

Keywords

BIO-key International, BKYI, Mira LaCous, Chief Technology Officer, Employee Stock Purchase Plan, Stock Acquisition, Form 4, Reverse Stock Split